A detailed history of State Board Of Administration Of Florida Retirement System transactions in Atara Biotherapeutics, Inc. stock. As of the latest transaction made, State Board Of Administration Of Florida Retirement System holds 31,145 shares of ATRA stock, worth $240,127. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,145
Previous 25,159 23.79%
Holding current value
$240,127
Previous $12,000 75.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$0.44 - $1.22 $2,633 - $7,302
5,986 Added 23.79%
31,145 $21,000
Q4 2023

Feb 09, 2024

BUY
$0.23 - $1.74 $5,786 - $43,776
25,159 New
25,159 $12,000
Q2 2022

Aug 05, 2022

BUY
$4.69 - $9.84 $46 - $98
10 Added 0.03%
31,145 $243,000
Q4 2021

Feb 08, 2022

BUY
$14.7 - $19.89 $8,849 - $11,973
602 Added 1.97%
31,135 $491,000
Q2 2021

Aug 10, 2021

BUY
$12.89 - $16.58 $17,117 - $22,018
1,328 Added 4.55%
30,533 $475,000
Q4 2020

Feb 08, 2021

BUY
$12.67 - $26.23 $76,273 - $157,904
6,020 Added 25.97%
29,205 $573,000
Q3 2020

Nov 09, 2020

BUY
$11.92 - $15.87 $9,059 - $12,061
760 Added 3.39%
23,185 $300,000
Q2 2019

Aug 05, 2019

BUY
$19.05 - $41.04 $63,055 - $135,842
3,310 Added 17.32%
22,425 $451,000
Q1 2019

May 03, 2019

BUY
$28.4 - $41.74 $5,964 - $8,765
210 Added 1.11%
19,115 $760,000
Q4 2018

Feb 01, 2019

BUY
$30.9 - $42.97 $30,869 - $42,927
999 Added 5.58%
18,905 $657,000
Q3 2018

Oct 31, 2018

BUY
$35.05 - $43.5 $21,380 - $26,535
610 Added 3.53%
17,906 $740,000
Q2 2018

Aug 06, 2018

BUY
$35.15 - $51.45 $135,327 - $198,082
3,850 Added 28.63%
17,296 $636,000
Q1 2018

May 04, 2018

BUY
$18.0 - $48.35 $57,474 - $154,381
3,193 Added 31.14%
13,446 $524,000
Q3 2017

Oct 31, 2017

BUY
$13.25 - $17.05 $135,852 - $174,813
10,253
10,253 $170,000

Others Institutions Holding ATRA

About Atara Biotherapeutics, Inc.


  • Ticker ATRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,362,304
  • Market Cap $728M
  • Description
  • Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...
More about ATRA
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.